GAVIOLI, Elaine Cristina
 Distribuzione geografica
Continente #
NA - Nord America 1.342
EU - Europa 285
AS - Asia 253
SA - Sud America 4
Totale 1.884
Nazione #
US - Stati Uniti d'America 1.326
CN - Cina 128
DE - Germania 83
SG - Singapore 80
IT - Italia 54
GB - Regno Unito 45
UA - Ucraina 45
TR - Turchia 36
FI - Finlandia 23
CA - Canada 16
SE - Svezia 11
PL - Polonia 8
BE - Belgio 7
ID - Indonesia 4
BR - Brasile 3
FR - Francia 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
LT - Lituania 2
CH - Svizzera 1
CL - Cile 1
IN - India 1
IR - Iran 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 1.884
Città #
Fairfield 187
Woodbridge 151
Ashburn 128
Houston 108
Chandler 88
Wilmington 81
Seattle 78
Cambridge 74
Singapore 69
Ann Arbor 62
Santa Clara 60
Jacksonville 56
Munich 48
Beijing 39
Nanjing 26
Izmir 25
Ferrara 18
Princeton 18
Mcallen 14
Montréal 14
Shanghai 14
Helsinki 12
New York 12
San Diego 12
Boardman 10
Milan 10
Shenyang 8
Warsaw 8
Brussels 7
Los Angeles 7
Falls Church 6
London 6
Washington 6
Nanchang 5
Bremen 4
Dearborn 4
Jakarta 4
Auburn Hills 3
Bari 3
Hebei 3
Norwalk 3
Padova 3
Falkenstein 2
Fort Huachuca 2
Frankfurt am Main 2
Guangzhou 2
Hong Kong 2
Indiana 2
Jiaxing 2
Lanzhou 2
Leawood 2
Mountain View 2
Philadelphia 2
Redwood City 2
Tianjin 2
Toronto 2
Zhengzhou 2
Ardabil 1
Augusta 1
Bratislava 1
Brno 1
Castellana Grotte 1
Changsha 1
Chiswick 1
Curitiba 1
Des Moines 1
Hangzhou 1
Hounslow 1
Islington 1
Jinan 1
La Canada Flintridge 1
Olomouc 1
Orange 1
Redmond 1
San Francisco 1
San Mateo 1
Shenzhen 1
Shijiazhuang 1
Taizhou 1
Tashkent 1
Trento 1
Yantai 1
Yellow Springs 1
Zurich 1
Totale 1.551
Nome #
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 168
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 155
Modulation of the NOP receptor signaling affects resilience to acute stress 137
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 133
The blockade of transient receptor potential ankirin 1 (TRPA1) signalling mediates antidepressant- and anxiolytic-like actions in mice 127
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 123
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands 123
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 118
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 112
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 109
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 106
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 93
Role of TRPA1 receptors in skin inflammation induced by volatile chemical irritants in mice 88
NOP agonist action of cebranopadol counteracts its liability to promote physical dependence 87
NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine 85
null 77
Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders 53
Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice 29
Totale 1.923
Categoria #
all - tutte 9.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020298 0 0 0 0 0 53 50 44 55 37 43 16
2020/2021297 26 45 34 25 21 26 4 32 7 36 23 18
2021/2022182 7 18 7 13 10 22 9 10 9 25 5 47
2022/2023182 17 12 9 20 37 24 9 9 31 0 7 7
2023/2024132 12 13 12 3 16 32 10 5 1 1 4 23
2024/2025253 17 20 40 51 56 69 0 0 0 0 0 0
Totale 1.923